Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 192

1.

Section 15. A desensitizing protocol without local graft infusion therapy and splenectomy is a safe and effective method in ABO-incompatible adult LDLT.

Song GW, Lee SG, Hwang S, Ahn CS, Kim KH, Moon DB, Ha TY, Jung DH, Park GC, Park HW, Park YH, Kang SH, Jung BH.

Transplantation. 2014 Apr 27;97 Suppl 8:S59-66. doi: 10.1097/01.tp.0000446279.81922.dd.

PMID:
24849837
2.

Rituximab, IVIG, and plasma exchange without graft local infusion treatment: a new protocol in ABO incompatible living donor liver transplantation.

Ikegami T, Taketomi A, Soejima Y, Yoshizumi T, Uchiyama H, Harada N, Iguchi T, Hashimoto N, Maehara Y.

Transplantation. 2009 Aug 15;88(3):303-7. doi: 10.1097/TP.0b013e3181adcae6.

PMID:
19667930
3.

Biliary stricture is the only concern in ABO-incompatible adult living donor liver transplantation in the rituximab era.

Song GW, Lee SG, Hwang S, Kim KH, Ahn CS, Moon DB, Ha TY, Jung DH, Park GC, Kang SH, Jung BH, Yoon YI, Kim N.

J Hepatol. 2014 Sep;61(3):575-82. doi: 10.1016/j.jhep.2014.04.039. Epub 2014 May 5.

PMID:
24801413
4.

Results of ABO-incompatible liver transplantation using a simplified protocol at a single institution.

Lee J, Lee JG, Lee JJ, Kim MS, Ju MK, Choi GH, Choi JS, Kim SI, Joo DJ.

Transplant Proc. 2015 Apr;47(3):723-6. doi: 10.1016/j.transproceed.2015.02.004.

PMID:
25891718
5.

Splenectomy does not offer immunological benefits in ABO-incompatible liver transplantation with a preoperative rituximab.

Raut V, Mori A, Kaido T, Ogura Y, Taku I, Nagai K, Sasaki N, Endo K, Hata T, Yagi S, Egawa H, Uemoto S.

Transplantation. 2012 Jan 15;93(1):99-105. doi: 10.1097/TP.0b013e318239e8e4.

PMID:
22094955
6.

Three-year outcomes following 1420 ABO-incompatible living-donor kidney transplants performed after ABO antibody reduction: results from 101 centers.

Opelz G, Morath C, Süsal C, Tran TH, Zeier M, Döhler B.

Transplantation. 2015 Feb;99(2):400-4. doi: 10.1097/TP.0000000000000312.

PMID:
25050471
7.

A modified protocol with rituximab and intravenous immunoglobulin in emergent ABO-incompatible liver transplantation for acute liver failure.

Shen T, Lin BY, Jia JJ, Wang ZY, Wang L, Ling Q, Geng L, Yan S, Zheng SS.

Hepatobiliary Pancreat Dis Int. 2014 Aug;13(4):395-401.

PMID:
25100124
8.

Potent immunosuppression for ABO-incompatible renal transplantation may not be a risk factor for malignancy.

Yamamoto T, Kawaguchi T, Watarai Y, Tujita M, Hiramitsu T, Nanmoku K, Goto N, Katayama A, Kobayashi T, Uchida K.

Transplant Proc. 2012 Jan;44(1):210-3. doi: 10.1016/j.transproceed.2011.11.048.

PMID:
22310616
9.

ABO-incompatible living donor liver transplantation without graft local infusion and splenectomy.

Lee SD, Kim SH, Kong SY, Kim YK, Lee SA, Park SJ.

HPB (Oxford). 2014 Sep;16(9):807-13. doi: 10.1111/hpb.12215. Epub 2014 Jan 28.

10.

Impact of rituximab desensitization on blood-type-incompatible adult living donor liver transplantation: a Japanese multicenter study.

Egawa H, Teramukai S, Haga H, Tanabe M, Mori A, Ikegami T, Kawagishi N, Ohdan H, Kasahara M, Umeshita K.

Am J Transplant. 2014 Jan;14(1):102-14. doi: 10.1111/ajt.12520. Epub 2013 Nov 26.

11.

Discrepancy of B cell frequency between periphery and spleen after rituximab treatment in ABO-incompatible liver transplantation.

Iso Y, Sawada T, Kita J, Shiraki T, Sakuraoka Y, Kato M, Shimoda M, Kubota K.

Hepatogastroenterology. 2013 Oct;60(127):1624-6.

PMID:
24634932
12.

Successful liver transplantation across the ABO incompatibility barrier in 6 cases of biliary atresia.

Yamada Y, Hoshino K, Morikawa Y, Okamura J, Hotta R, Komori K, Nakao S, Obara H, Kawachi S, Fuchimoto Y, Tanabe M, Shimazu M, Kitajima M.

J Pediatr Surg. 2006 Dec;41(12):1976-9.

PMID:
17161185
13.

ABO-Incompatible Adult Living Donor Liver Transplantation Under the Desensitization Protocol With Rituximab.

Song GW, Lee SG, Hwang S, Kim KH, Ahn CS, Moon DB, Ha TY, Jung DH, Park GC, Kim WJ, Sin MH, Yoon YI, Kang WH, Kim SH, Tak EY.

Am J Transplant. 2016 Jan;16(1):157-70. doi: 10.1111/ajt.13444. Epub 2015 Sep 15.

14.

Strategic breakthrough in adult ABO-incompatible living donor liver transplantation: preliminary results of consecutive seven cases.

Soejima Y, Muto J, Matono R, Ninomiya M, Ikeda T, Yoshizumi T, Uchiyama H, Ikegami T, Shirabe K, Maehara Y.

Clin Transplant. 2013 Mar-Apr;27(2):227-31. doi: 10.1111/ctr.12060. Epub 2013 Jan 7.

PMID:
23293980
16.

Long-term recurrence-free survival after liver transplantation from an ABO-incompatible living donor for treatment of hepatocellular carcinoma exceeding Milano criteria in a patient with hepatitis B virus cirrhosis: a case report.

Nakamura Y, Hama K, Iwamoto H, Yokoyama T, Kihara Y, Konno O, Jojima Y, Shimazu M.

Transplant Proc. 2012 Mar;44(2):565-9. doi: 10.1016/j.transproceed.2012.01.029.

PMID:
22410070
18.

Evaluation of two different preconditioning regimens for ABO-incompatible living kidney donor transplantation. A comparison of splenectomy vs. rituximab-treated non-splenectomy preconditioning regimens.

Tanabe K, Ishida H, Shimizu T, Omoto K, Shirakawa H, Tokumoto T.

Contrib Nephrol. 2009;162:61-74. doi: 10.1159/000170813. Epub 2008 Oct 31.

PMID:
19001814
19.

Present status of ABO-incompatible living donor liver transplantation in Japan.

Egawa H, Teramukai S, Haga H, Tanabe M, Fukushima M, Shimazu M.

Hepatology. 2008 Jan;47(1):143-52.

PMID:
17929298
20.

Current progress in ABO-incompatible liver transplantation.

Tanabe M, Kawachi S, Obara H, Shinoda M, Hibi T, Kitagawa Y, Wakabayashi G, Shimazu M, Kitajima M.

Eur J Clin Invest. 2010 Oct;40(10):943-9. doi: 10.1111/j.1365-2362.2010.02339.x. Epub 2010 Aug 19. Review.

PMID:
20636381

Supplemental Content

Support Center